KEQU: Sales and earnings declined year-over-year, but backlog and international margins improved
Czytanie zajmuje mniej niż 1 minutę
First quarter FY2027 saw a 6.7% sales decline and a 44.8% drop in net earnings year-over-year, with backlog rising sequentially but remaining below last year. International segment profitability improved on higher-margin projects, while cost discipline and non-recurring compensation expenses shaped results.
Original document: Kewaunee Scientific Corporation [KEQU] SEC 8-K Current Report — Sep. 9 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr